What a treatment is, who regulates it, and what to ask. 186 articles, newest first.
Addyi and Vyleesi are FDA-approved products for different labeled populations with acquired, generalized HSDD, routes, and schedules. No testosterone product is FDA approved in the United States for female sexual dysfunction, so off-label and compounded testosterone follow different product and evidence pathways.
An off-the-shelf adipose allograft comes from donor tissue, an autologous fat graft is harvested from the same patient during surgery, and dermal filler is a manufactured implant with product-specific FDA approvals. They do not share one regulatory path, evidence base, reversibility profile, or treatment record.
Alarplasty changes the nostril base through limited sill or alar excisions; rhinoplasty can change the broader nasal framework. A small incision does not make the decision small: base width, flare, symmetry, scars, tip support, and breathing still need one plan.
An at-home red/blue LED acne device and a prescription 1726-nm clinic laser use different wavelengths, targets, controls, treatment schedules, claims, evidence, and operators. FDA clearance belongs to an exact model and indication; it does not make every acne light equivalent or establish a universal winner.
A beard or mustache transplant moves follicles; it does not create a separate facial-hair type. The plan should protect the donor supply and match caliber, curl, color, growth behavior, border softness, direction, density priorities, grooming, scarring, and future hair-loss needs.
A breast-reduction skin pattern controls the external envelope and scar; a pedicle preserves a tissue connection to the nipple-areola complex; a free nipple graft detaches and grafts that complex. These choices are related but not interchangeable, and no single size cutoff determines the plan for everyone.
A cheek implant adds a shaped solid device at the skeleton, filler adds a manufactured injectable at selected planes, and fat grafting transfers living tissue from a donor site. The right comparison starts with the missing three-dimensional structure, not the word “volume.”
Dermaplaning uses a blade to remove surface scale and vellus hair; microdermabrasion uses controlled abrasion, often with suction; a superficial chemical peel uses a defined agent to create a controlled chemical injury. The evidence, depth, recovery, sanitation, and skin-fit questions are different.
Hand filler and fat grafting address dorsal volume loss through different product and procedure pathways. Lasers, light devices, and peels target surface findings such as pigment or texture instead. A useful plan identifies the primary deficit before combining treatments.
Laser hair removal aims for stable long-term reduction through repeated light-based treatment of suitable pigment targets. Waxing and sugaring pull visible hair from the root for a temporary result. Compare hair color and cycle, skin response, interval, irritation, maintenance, provider, and total course.
“MIC,” “lipotropic,” and “skinny shot” are not standardized finished products. Methionine, inositol, choline, B12, carnitine, and other ingredients can vary by clinic and pharmacy; evidence for one oral nutrient or deficiency treatment does not prove that an injected mixture causes weight loss.
Ear pinning is not one maneuver. A complete otoplasty plan identifies the antihelical fold, conchal depth, ear-to-head angle, lobe, asymmetry, cartilage strength, incisions, sutures, and whether cartilage is bent, scored, removed, or combined.
Phentermine is a Schedule IV sympathomimetic labeled as short-term adjunct therapy, while FDA-approved GLP-1 or dual-incretin weight-management products have product-specific chronic-use labels. They differ in mechanism, route, contraindications, monitoring, continuity, cost, and evidence—not just speed or price.
Round and anatomical implants differ in geometry and orientation behavior, but shape does not determine fill, surface, profile, dimensions, pocket, or surgical result by itself. Compare the exact implant models and the anatomy-based plan rather than treating teardrop and natural as synonyms.
Zepbound has an FDA-approved obstructive-sleep-apnea indication for a defined group of adults with obesity, but it does not diagnose OSA or automatically replace PAP. The useful plan connects the exact drug label, weight-management care, sleep testing, current therapy, symptoms, and repeat assessment.
Home and office RF can share an energy family without sharing intended use, exposure, controls, endpoint, operator, or evidence. A home-use clearance applies to one named device and label; it does not make consumer RF equivalent to professional surface RF or RF microneedling.
Breast implant revision is the umbrella operation; exchange replaces an implant, while explant removes it without automatic replacement. Any pathway may also include capsule work, pocket repair, lift, fat grafting, scar revision, tissue removal, or reconstruction.
An excisional buttock lift removes and repositions loose skin and tissue; a Brazilian butt lift uses liposuction and fat grafting to add or redistribute volume. One does not substitute for the other when the primary problem is different.
Canthopexy reinforces the lateral eyelid corner; canthoplasty more structurally releases and reconstructs or repositions it; blepharoplasty changes eyelid skin, fat, and related tissues. They can be alternatives or combined components, depending on lid position, support, eye surface, and goals.
FUE describes how follicular units are excised from the donor area. DHI commonly describes immediate placement with a sharp implanter in the recipient area. A clinic can use both in one operation, so they are not competing full-procedure categories.
Endoscopic sleeve gastroplasty reduces stomach volume with full-thickness sutures placed through the mouth; sleeve gastrectomy surgically removes most of the stomach. They differ in anatomy, eligibility, evidence, risks, reversibility, follow-up, coverage, and rescue options.
Endoscopic and open brow lifts are access families, not a simple minimally invasive versus durable ranking. Compare the brow region, forehead and hairline anatomy, incision, release, fixation, muscle work, scar and sensory tradeoffs, evidence, and any eyelid or facial procedures.
Structural fat and microfat are used to place viable adipose parcels for volume; nanofat is more heavily processed, contains little or no intact adipocyte architecture, and is studied mainly for skin-quality applications. The labels still do not define one standardized preparation.
Festoons, lower-eyelid fat bags, tear-trough hollows, malar edema, and loose skin are not synonyms. They occupy different layers and locations, can coexist, and do not share a universal filler, laser, or surgical solution. Accurate feature mapping comes before treatment selection.
Forehead reduction advances the existing hair-bearing scalp and removes upper-forehead skin; hair transplantation redistributes follicles into a designed hairline. They differ in immediate density, scalp mobility, scars, donor supply, future hair loss, and staging—and can sometimes be combined.
Some laser or LED hair-growth caps are FDA cleared for narrowly described pattern-hair-loss populations, but clearance is device specific. It does not diagnose the cause of shedding, prove every cap works, transfer between models, or establish that light is the right first step for a particular hair-loss pattern.
Liposuction for clinically assessed lipedema and liposuction for elective contouring can use related instruments, but they begin with different diagnoses, goals, documentation, conservative-care history, anatomical maps, outcome measures, and long-term plans.
Low-dose naltrexone is an off-label dosing approach, not a distinct FDA-approved drug indication or standardized product. Verify the exact formulation, prescribed purpose, evidence, opioid screen, compounding record, and follow-up plan.
Lower-eyelid fat can be selectively removed, left in place, repositioned on a pedicle, or supplemented with grafted fat. First distinguish a true fat bulge from a tear-trough hollow, edema, festoon, skin change, lid laxity, and midface anatomy.
Micro-coring removes tiny full-thickness columns of skin without thermal energy; microneedling creates punctures without intentionally removing cores; laser resurfacing delivers controlled optical energy to tissue. Their mechanisms, endpoints, downtime, evidence, and device records are not interchangeable.
A Myers cocktail is not one standardized FDA-approved drug. Formulas, compounders, concentrations, sterility controls, claims, and evidence vary. The September 2026 recall applies to specified Centric Compounding lots—not to every Myers cocktail.
Septoplasty changes a deviated septum; nasal valve repair targets narrowing or collapse at the internal or external nasal valve. The procedures can be complementary, but a septoplasty alone does not automatically correct valve dysfunction.
Open and closed neck lifts describe access, not one standardized pair of operations. Open access generally adds a submental incision; closed access works without it. The decisive comparison is the actual skin, fat, platysma, gland, digastric, fixation, and facelift plan.
Oral rehydration solution is often effective when drinking is possible and the situation is appropriate; IV fluid is used when severity or another clinical factor requires venous access and monitoring. IV is not automatically better hydration, and ORS is not the same as water or a sports drink.
Picosecond and Q-switched lasers deliver very short pulses, but pulse duration alone does not decide tattoo clearance. Wavelength, pigment chemistry and depth, fluence, spot size, skin type, prior response, endpoint, interval, and the exact device matter together.
Septal, ear, autologous rib, and donor rib cartilage differ in shape, available volume, strength, donor-site burden, processing, and long-term evidence. The best source depends on the graft job and the patient's anatomy—not a universal material ranking.
Rib remodeling, partial rib resection, liposuction, and abdominoplasty target different structures. Remodeling changes rib shape without removing the full segment; current evidence is mostly selected short-term series and does not establish universal safety, permanence, or superiority.
Microneedling creates mechanical channels; fractional lasers create columns of thermal or ablative injury. Evidence for stretch marks depends on whether striae are red or white, the body site, skin type, exact laser, needling method, endpoint, sessions, pigment risk, and follow-up.
The Allurion balloon became the first FDA-approved swallowable, self-emptying intragastric balloon in February 2026. It still requires clinician placement steps, imaging confirmation, lifestyle care, follow-up, and rescue capability; it is not interchangeable with endoscopically placed and removed systems.
Temple filler is not approved as a category. FDA approval belongs to a named product, a defined indication, an age range, an injection plane, and its labeling; a March 2026 supplement added temple hollowing for one Restylane product, not every filler or every temple technique.
Trim labiaplasty removes tissue along the labial edge; a central-wedge design removes a segment while preserving more of the native edge. Neither is universally superior, and each label still leaves anatomy, extent, tension, sensation, function, scars, and revision planning undefined.
A bra-line back lift usually targets a horizontal roll or loose skin across the upper back; “upper-body lift” may describe a broader combination involving the back, lateral chest, breast, or arm junctions. Neither label defines the scar or complete operation by itself.
An FDA-cleared microcurrent device is cleared only for the named model and intended use in its decision record. Facial or neck stimulation clearance does not automatically cover a later device, conductive gel, or claims about lifting, collagen, acne, pigmentation, lymphatic drainage, or the microbiome.
BOTOX for chronic migraine and BOTOX Cosmetic contain onabotulinumtoxinA but follow different labeled purposes and protocols. Verify the product, indication, dose map, clinician, outcome records, and coverage pathway instead of comparing only a price per unit.
BOTOX Cosmetic is FDA approved for temporary improvement of moderate to severe platysma bands associated with platysma activity in adults. That product-specific indication does not make every toxin, neck line, lax-skin concern, submental treatment, or “Nefertiti lift” claim on-label.
A one-stage augmentation-mastopexy adds volume and reshapes the breast envelope in one operation. A staged plan separates those jobs so position, healing, or implant choice can be reassessed. Compare skin and tissue, nipple position, volume, device plan, recovery, total burden, and revision tolerance.
A surgical brow lift repositions brow and forehead tissues through incisions and fixation. A Botox “brow lift” is an off-label injection strategy that temporarily changes muscle balance; it cannot remove skin or reproduce fixation. Compare brow position, eyelid findings, muscle behavior, hairline, and desired change.
FDA's 2025 advisory-panel materials identified adverse-event reports and published cases of bone resorption after some supraperiosteal hyaluronic-acid filler injections. The evidence is a safety signal, not a measured population incidence or proof that all fillers, planes, areas, durations, or patients cause bone loss.
